Discovery Investment Research Provides Update on Medexus Pharma – iCrowdNewswire
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Sep 12, 2019 3:07 AM ET

Discovery Investment Research Provides Update on Medexus Pharma


iCrowd Newswire - Sep 12, 2019

PHOENIX, AZ Discovery Investment Research (DIR), an equity research firm specializing in micro and small-cap stocks, announces the availability of a research update on Medexus Pharma (PDDPF) (MDP). The update on Medexus Pharma, a specialty pharmaceutical company with operations in Canada and the United States, can be obtained by visiting DIR’s website (www.discoveryinvresearch.com). The following key attributes serve as the basis for DIR’s current recommendation:

About Pediapharm

Pediapharm is a specialty pharmaceutical company with operations in both Canada and the United States. The company markets several products aimed at niche markets for both children and adults, including pharmaceuticals for Rheumatoid Arthritis and other auto-immune disorders.



Contact Information:

Roland Boivin
Chief Financial Officer
Pediapharm Inc. Tel.: 514-762-2626 ext. 202 E-mail: [email protected]
Frank Candido
Direct Financial Strategies and Communication Inc.
Tel. 514-969-5530 E-mail: [email protected]








Tags:    Profitwire, Wire, United States, English